Lesley A. Patmore
YOU?
Author Swipe
View article: HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER) Open
Background Peg-interferon (peg-IFN) plays an increasingly important role in HBV cure strategies, either in combination with novel antivirals, as a lead-in or as consolidation treatment. Objective We aimed to provide estimates of hepatitis …
View article: Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction—Do Existing Scores Clear the Bar? Authors' Reply
Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction—Do Existing Scores Clear the Bar? Authors' Reply Open
View article: Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis Open
View article: Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B
Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B Open
Presence of metabolic comorbidities in untreated CHB patients is associated with more severe liver fibrosis and, after initiation of antiviral therapy, with less fibrosis regression and a higher risk of fibrosis progression.
View article: Low rate of hepatitis Delta virus co‐infection in first‐time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands
Low rate of hepatitis Delta virus co‐infection in first‐time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands Open
Background Hepatitis Delta virus (HDV) requires co‐infection with hepatitis B virus (HBV) and increases the risk of hepatitis‐related morbidity and mortality compared to HBV mono‐infection. HBV/HDV co‐infected patients will likely benefit …
View article: The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B Open
Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with an increased risk of liver‐related events in patients with chronic hepatitis B (CHB), possibly by accelerating fibrosis progression. Th…
View article: Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals
Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals Open
Anti-HDV-positive individuals are at high risk of adverse liver-related outcomes. The incidence of HCC was negligible among individuals without cirrhosis and among individuals with low baseline PAGE-B and/or Fibrosis-4 scores. Therefore, t…
View article: Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe Open
Sub-Saharan African ethnicity has been associated with a higher risk of hepatocellular carcinoma among individuals with chronic hepatitis B. In this international multicenter cohort study of sub-Saharan African and Afro-Surinamese individu…
View article: Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B Open
View article: Hepatocellular Carcinoma Risk in Sub-Saharan African and Afro-Surinamese Individuals with Chronic Hepatitis B Living in Europe: An International Multicenter Retrospective Cohort Study
Hepatocellular Carcinoma Risk in Sub-Saharan African and Afro-Surinamese Individuals with Chronic Hepatitis B Living in Europe: An International Multicenter Retrospective Cohort Study Open